SPR for molecular interaction analysis: A review of emerging application areas

Journal of Molecular Recognition

Volumn 17, Issue 3, 2004, Pages 151-161

  Karlsson, Robert ^a  

^a BIACORE AB   (Sweden)

Author keywords

ADME; Biacore; Drug discovery; Food analysis; Immunogenicity; Proteomics; Surface plasmon resonance

Indexed keywords

ANTIGEN;

CONFERENCE PAPER; DRUG SCREENING; FOOD ANALYSIS; HUMAN; IMMUNOLOGY; METHODOLOGY; PROTEOMICS; SURFACE PLASMON RESONANCE;

ANTIGENS; DRUG EVALUATION, PRECLINICAL; FOOD ANALYSIS; HUMANS; PROTEOMICS; SURFACE PLASMON RESONANCE;

EID: 2542465914     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.660     Document Type: Conference Paper

References (74)

1. Bailly C, Carrasco C, Joubert A, Bal C, Wattez N, Hildebrand MP, Lansiaux A, Colson P, Houssier C, Cacho M, Ramos A, Brana MF. 2003. Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides. Biochemistry 42(14): 4136-4150.
2. Baird CL, Courtenay ES, Myszka DG. 2002. Surface plasmon resonance characterization of drug/liposome interactions. Anal. Biochem. 310(1): 93-99.
3. Baxter GA, Ferguson JP, O'Connor MC, Elliott CT. 2001. Detection of streptomycin residues in whole milk using an optical immunobiosensor. J. Agric. Food Chem. 49(7): 3204-3207.
4. Berezov A, Zhang HT, Greene MI, Murali R. 2001. Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis. J. Med. Chem. 44(16): 2565-2574.
5. Berezov A, Chen J, Liu Q, Zhang HT, Greene MI, Murali R. 2002. Disabling receptor ensembles with rationally designed interface peptidomimetics. J. Biol. Chem. 277(31): 28330-28339. [Epub 2002 May 14].
6. Bjurling P, Baxter GA, Caselunghe M, Jonson C, O'Connor M, Persson B, Elliott CT. 2000. Biosensor assay of sulfadiazine and sulfamethazine residues in pork. Analyst 125(10): 1771-1774.
7. Bokken GC, Corbee RJ, van Knapen F, Bergwerff AA. 2003. Immunochemical detection of Salmonella group B, D and E using an optical surface plasmon resonance biosensor. FEMS Microbiol. Lett. 222(1): 75-82.
8. Boström Caselunghe M, Lindeberg J. 2000. Biosensor-based determination of folic acid in fortified food. Food Chem. 70: 523-532.
9. Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T, Juan T, Talvenheimo J, Montestruque S, Sun J, Elliott G, Thomas J, Ferbas J, Kern B, Briddell R, Leonard JP, Cesano A. 2003. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Clin. Cancer Res. 9(10): 3982S-3990S.
10. Carrasco C, Vezin H, Wilson WD, Ren J, Chaires JB, Bailly C. 2001. DNA binding properties of the indolocarbazole antitumor drug NB-506. Anticancer Drug Des. 16(2-3): 99-107.
11. Carrasco C, Rosu F, Gabelica V, Houssier C, De Pauw E, Garbay-Jaureguiberry C, Roques B, Wilson WD, Chaires JB, Waring MJ, Bailly C. 2002a. Tight binding of the antitumor drug ditercalinium to quadruplex DNA. Chembiochemistry 3(12): 1235-1241.
12. Carrasco C, Facompre M, Chisholm JD, Van Vranken DL, Wilson WD, Bailly C. 2002b. DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer. Nucl. Acids Res. 30(8): 1774-1781.
13. Carrasco C, Helissey P, Haroun M, Baldeyrou B, Lansiaux A, Colson P, Houssier C, Giorgi-Renault S, Bailly C. 2003. Design of a composite ethidium-netropsin-anilinoacridine molecule for DNA recognition. Chembiochemistry 4(1): 50-61.
14. Danelian E, Karlen A, Karlsson R, Winiwarter S, Hansson A, Lofas S, Lennernas H, Hamalainen MD. 2000. SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. J. Med. Chem. 43(11): 2083-2086.
15. Day YS, Myszka DG. 2003. Characterizing a drug's primary binding site on albumin. J. Pharm. Sci. 92(2): 333-343.
16. Deckert F, Legay F. 2000. Development and validation of an IL-6 immuno-receptor assay based on surface plasmon resonance. J. Pharm. Biomed. Anal. 23(2-3): 403-412.
17. Deinum J, Gustavsson L, Gyzander E, Kullman-Magnusson M, Edstrom A, Karlsson R. 2002. A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry. Anal. Biochem. 300(2): 152-162.
18. Facompre M, Carrasco C, Colson P, Houssier C, Chisholm JD, Van Vranken DL, Bailly C. 2002. DNA binding and topoisomerase I poisoning activities of novel disaccharide indolocarbazoles. Mol. Pharmac. 62(5): 1215-1227.
19. Facompre M, Carrasco C, Vezin H, Chisholm JD, Yoburn JC, Van Vranken DL, Bailly C. 2003. Indolocarbazole glycosides in inactive conformations. Chembiochemistry 4(5): 386-395.
20. Ferguson JP, Baxter GA, McEvoy JD, Stead S, Rawlings E, Sharman M. 2002. Detection of streptomycin and dihydrostreptomycin residues in milk, honey and meat samples using an optical biosensor. Analyst 127(7): 951-956.
21. Frostell-Karlsson A, Remaeus A, Roos H, Andersson K, Borg P, Hamalainen M, Karlsson R. 2000. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem. 43(10): 1986-1992.
22. Gambari R, Feriotto G, Rutigliano C, Bianchi N, Mischiati C. 2000. Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs. J. Pharmac. Exp. Ther. 294(1): 370-377.
23. Gilligan JJ, Schuck P, Yergey AL. 2002. Mass spectrometry after capture and small-volume elution of analyte from a surface plasmon resonance biosensor. Anal. Chem. 74(9): 2041-2047.
24. Gonzales NR, Schuck P, Schlom J, Kashmiri SV. 2002. Surface plasmon resonance-based competition assay to assess the sera reactivity of variants of humanized antibodies. J. Immunol. Meth. 268(2): 197-210.
25. Haughey SA, Baxter GA, Elliott CT, Persson B, Jonson C, Bjurling P. 2001. Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay. J. AOAC Int. 84(4): 1025-1030.
26. Helg A, Mueller MS, Joss A, Poltl-Frank F, Stuart F, Robinson JA, Pluschke G. 2003. Comparison of analytical methods for the evaluation of antibody responses against epitopes of polymorphic protein antigens. J. Immunol. Meth. 276(1-2): 19-31.
27. Hoffrogge R, Mikschofsky H, Piechulla B. 2003. Surface plasmon resonance spectroscopy (SPR) interaction studies of the circadian-controlled tomato LHCa4*1 (CAB 11) protein with its promoter. Chronobiol. Int. 20(4): 543-558.
28. Homola J, Dostalek J, Chen S, Rasooly A, Jiang S, Yee SS. 2002. Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk. Int. J. Food Microbiol. 75(1-2): 61-69.
29. Hornemann T, Kempa S, Himmel M, Hayess K, Furst DO, Wallimann T. 2003. Muscle-type creatine kinase interacts with central domains of the M-band proteins myomesin and M-protein. J. Mol. Biol. 332(4): 877-887.
30. Houseman BT, Huh JH, Kron SJ, Mrksich M. 2002. Peptide chips for the quantitative evaluation of protein kinase activity. Nat. Biotechnol. 20(3): 270-274.
31. Indyk HE, Evans EA, Bostrom Caselunghe MC, Persson BS, Finglas PM, Woollard DC, Filonzi EL. 2000. Determination of biotin and folate in infant formula and milk by optical biosensor-based immunoassay. J. AOAC Int. 83(5): 1141-1148.
32. 12 in milk products and selected foods by optical biosensor protein-binding assay: method comparison. J. AOAC Int. 85(1): 72-81.
33. Karlsson R. 1999. Affinity analysis of non-steady-state data obtained under mass transport limited conditions using BIAcore technology. J. Mol. Recognit. 12(5): 285-292.
34. Karlsson OP, Löfås S. 2002. Flow-mediated on-surface reconstitution of G-protein coupled receptors for applications in surface plasmon resonance biosensors. Anal. Biochem. 300(2): 132-138.
35. Karlsson R, Ståhlberg R. 1995. Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities. Anal. Biochem. 228(2): 274-280.
36. Karlsson R, Michaelsson A, Mattsson L. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Meth. 145(1-2): 229-240.
37. Karlsson R, Fagerstam L, Nilshans H, Persson B. 1993. Analysis of active antibody concentration. Separation of affinity and concentration parameters. J. Immunol. Meth. 166(1): 75-84.
38. Karlsson R, Mo JA, Holmdahl R. 1995. Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and the secondary immune response investigated with the biosensor technique. J. Immunol. Meth. 188(1): 63-71.
39. Kikuchi J, Furukawa Y, Hayashi N. 2003. Identification of novel p53-binding proteins by biomolecular interaction analysis combined with tandem mass spectrometry. Mol. Biotechnol. 23(3): 203-212.
40. Lansiaux A, Tanious F, Mishal Z, Dassonneville L, Kumar A, Stephens CE, Hu Q, Wilson WD, Boykin DW, Bailly C. 2002. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution. Cancer Res. 62(24): 7219-7229.
41. Lee KJ, Mao S, Sun C, Gao C, Blixt O, Arrues S, Hom LG, Kaufmann GF, Hoffman TZ, Coyle AR, Paulson J, Felding-Habermann B, Janda KD, 2002. Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigen. J. Am. Chem. Soc. 124(42): 12439-12446.
42. Liu Z, Panousis C, Smyth FE, Murphy R, Wirth V, Cartwright G, Johns TG, Scott AM. 2003. Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses. Hybrid Hybridom. 22(4): 219-228.
43. Lopez F, Pichereaux C, Burlet-Schiltz O, Pradayrol L, Monsarrat B, Esteve JP. 2003. Improved sensitivity of biomolecular interaction analysis mass spectrometry for the identification of interacting molecules. Proteomics 3(4): 402-412.
44. Löfås S, Johnsson B. 1990. A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands. J. Chem. Soc. Chem. Commun. 21: 1526-1528.
45. Mandine E, Gofflo D, Jean-Baptiste V, Sarubbi E, Touyer G, Deprez P, Lesuisse D. 2001. Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance. J. Mol. Recognit. 14(4): 254-260.
46. Markgren PO, Schaal W, Hamalainen M, Karlen A, Hallberg A, Samuelsson B, Danielson UH. 2002. Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. J. Med. Chem. 45(25): 5430-5439.
47. Morton TA, Myszka DG, Chaiken IM. 1995. Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal. Biochem. 227(1): 176-185.
48. Murphy MB, Fuller ST, Richardson PM, Doyle SA. 2003. An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucl. Acids Res. 31(18): e110.
49. Natsume T, Nakayama H, Isobe T. 2001. BIA-MS-MS: biomolecular interaction analysis for functional proteomics. Trends Biotechnol. 19(Suppl. 10): S28-S33.
50. Nedelkov D, Nelson RW. 2003a. Detection of Staphylococcal enterotoxin B via biomolecular interaction analysis mass spectrometry. Appl. Environ. Microbiol. 69(9): 5212-5215.
51. Nedelkov D, Nelson RW. 2003b. Surface plasmon resonance mass spectrometry: recent progress and outlooks. Trends Biotechnol. 21(7): 301-305.
52. Nedelkov D, Rasooly A, Nelson RW. 2000. Multitoxin biosensormass spectrometry analysis: a new approach for rapid, real-time, sensitive analysis of staphylococcal toxins in food. Int. J. Food Microbiol. 60(1): 1-13.
53. Nguyen B, Tardy C, Bailly C, Colson P, Houssier C, Kumar A, Boykin DW, Wilson WD. 2002. Influence of compound structure on affinity, sequence selectivity, and mode of binding to DNA for unfused aromatic dications related to furamidine. Biopolymers 63(5): 281-297.
54. Oda Y, Owa T, Sato T, Boucher B, Daniels S, Yamanaka H, Shinohara Y, Yokoi A, Kuromitsu J, Nagasu T. 2003. Quantitative chemical proteomics for identifying candidate drug targets. Anal. Chem. 75(9): 2159-2165.
55. Ohman L, Gedda L, Hesselager G, Larsson R, Nister M, Stigbrand T, Wester K, Carlsson J. 2002. A new antibody recognizing the vIII mutation of human epidermal growth factor receptor. Tumour Biol. 23(2): 61-69.
56. Park J, Fu H, Pei D. 2003. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains. Biochemistry 42(17): 5159-5167.
57. Rasooly A. 2001. Surface plasmon resonance analysis of staphylococcal enterotoxin B in food. J. Food Prot. 64(1): 37-43.
58. Rich RL, Day YS, Morton TA, Myszka DG. 2001. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Anal. Biochem. 296(2): 197-207.
59. Rich RL, Hoth LR, Geoghegan KF, Brown TA, LeMotte PK, Simons SP, Hensley P, Myszka DG. 2002. Kinetic analysis of estrogen receptor/ligand interactions. Proc. Natl Acad. Sci USA 99(13): 8562-8567.
60. Ritter G, Cohen LS, Williams C Jr, Richards EC, Old LJ, Welt S. 2001. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. Cancer Res. 61(18): 6851-6859.
61. Shelver WL, Smith DJ. 2003. Determination of ractopamine in cattle and sheep urine samples using an optical biosensor analysis: comparative study with HPLC and ELISA. J. Agric. Food Chem. 51(13): 3715-3721.
62. Shen B, Shimmon S, Smith MM, Ghosh P. 2003. Biosensor analysis of the molecular interactions of pentosan polysulfate and of sulfated glycosaminoglycans with immobilized elastase, hyaluronidase and lysozyme using surface plasmon resonance (SPR) technology. J. Pharm. Biomed. Anal. 31(1): 83-93.
63. Smith SA, Sreenivasan R, Krishnasamy G, Judge KW, Murthy KH, Arjunwadkar SJ, Pugh DR, Kotwal GJ. 2003. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochim. Biophys. Acta 1650(1-2): 30-39.
64. Swanson SJ. 2003. New technologies for the detection of antibodies to therapeutic proteins. Dev. Biol. (Basel) 112: 127-133.
65. Swanson SJ, Mytych D, Ferbas J. 2002. Use of biosensors to monitor the immune response. Dev. Biol. (Basel) 109: 71-78.
66. Thurmond RL, Wadsworth SA, Schafer PH, Zivin RA, Siekierka JJ. 2001. Kinetics of small molecule inhibitor binding to p38 kinase. Eur. J. Biochem. 268(22): 5747-5754.
67. Tsurumi Y, Hayakawa M, Shibata Y, Abiko Y. 2003. Production of antibody against a synthetic peptide of Porphyromonas gingivalis 40-kDa outer membrane protein. J. Oral Sci. 45(2): 111-116.
68. Tudos AJ, Lucas-van den Bos ER, Stigter EC. 2003. Rapid surface plasmon resonance-based inhibition assay of deoxynivalenol. J. Agric. Food Chem. 51(20): 5843-5848.
69. Van Regenmortel MH. 1994. Use of biosensors to characterize recombinant proteins. Dev. Biol. Stand. 83: 143-151.
70. van Remoortere A, van Dam GJ, Hokke CH, van den Eijnden DH, van Die I, Deelder AM. 2001. Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance. Infect. Immun. 69(4): 2396-2401.
71. Wadhwa M, Bird C, Dilger P, Gaines-Das R, Thorpe R. 2003. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J. Immunol. Meth. 278(1-2): 1-17.
72. Welt S, Ritter G, Williams C Jr, Cohen LS, John M, Jungbluth A, Richards EA, Old LJ, Kemeny NE. 2003. Phase I study of anticolon cancer humanized antibody a33. Clin. Cancer Res. 9(4): 1338-1346.
73. Wilkinson FL, Holaska JM, Zhang Z, Sharma A, Manilal S, Holt I, Stamm S, Wilson KL, Morris GE. 2003. Emerin interacts in vitro with the splicing-associated factor, YT521-B. Eur. J. Biochem. 270(11): 2459-2466.
74. Wilson S, Howell S. 2002. High-throughput screening in the diagnostics industry. Biochem. Soc. Trans. 30(4): 794-797.